1,047 results on '"Wilson, John T."'
Search Results
2. Bathymetric surveys of Morse and Geist Reservoirs in central Indiana made with acoustic Doppler current profiler and global positioning system technology, 1996
3. Revision reverse shoulder arthroplasty for the management of baseplate failure: an analysis of 676 revision reverse shoulder arthroplasty procedures
4. Changepoint Analysis of Natural Attenuation in Groundwater Improves Forecasts of Time to Attain Goal
5. FIGURE 6 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
6. Figure S2 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
7. FIGURE 3 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
8. FIGURE 2 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
9. Table S4 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
10. FIGURE 4 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
11. FIGURE 5 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
12. Data from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
13. FIGURE 1 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
14. Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy
15. STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of Inflammatory Diseases
16. STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy
17. Pandora's PFAS box: Life cycle exposure considerations of treatment options for PFAS in groundwater
18. A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
19. A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA
20. Establishing the prevalence and relative rates of 1,4-dioxane biodegradation in groundwater to improve remedy evaluations
21. Evaluation of natural attenuation of 1,4-dioxane in groundwater using a 14C assay
22. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T-Cell Response
23. Does Insurance Status Affect Access to Care Among Ankle Fracture Patients? An Institutional Retrospective Study
24. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
25. Populations using public-supply groundwater in the conterminous U.S. 2010; Identifying the wells, hydrogeologic regions, and hydrogeologic mapping units
26. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
27. A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery
28. Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations
29. TABLE 1 from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
30. FIGURE 2 from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
31. Supplementary Table 1 from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
32. FIGURE 5 from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
33. Data from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
34. Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
35. Revision reverse shoulder arthroplasty for the management of baseplate failure: an analysis of 676 revision reverse shoulder arthroplasty procedures
36. Factors Associated with Low and High Article Citations in Four Prominent Orthopaedic Surgery Journals
37. Microparticle Depots for Controlled and Sustained Release of Endosomolytic Nanoparticles
38. Bioventing Reclamation Pilot Project Aviation Gasoline Spill
39. Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
40. STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
41. Impacts of an ethanol‐blended fuel release on groundwater and fate of produced methane: Simulation of field observations
42. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
43. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model
44. A Nanoparticle RIG-I Agonist for Cancer Immunotherapy
45. Figure S3 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
46. Data from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
47. Supplemental Figure S1 from Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
48. Data from Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
49. IQGAP2 regulates blood-brain barrier immune dynamics
50. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.